PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Fortitech, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Fortitech, Inc. Continues Corporate Marketing Growth to Drive Premix Innovation and Market Expansion - Fortitech, Inc. hires new Director of Marketing; Expands Marketing department
Fortitech, Inc. Continues Corporate Marketing Growth to Drive Premix Innovation and Market Expansion

 

NewswireToday - /newswire/ - Schenectady, NY, United States, 2006/10/30 - Fortitech, Inc. hires new Director of Marketing; Expands Marketing department.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

In a proactive effort to drive sales, Fortitech, Inc., the world leader in custom nutrient premixes, is pleased to announce the addition of Richard Schleif as its new director of marketing. Reporting directly to President and CEO Walter Borisenok, Schleif will be responsible for Fortitech’s overall marketing and strategic planning programs including market and business development, global advertising and public relations, direct/email marketing, collateral materials, trade shows, web marketing, and sales and distributor education support on a worldwide basis. Schleif will also be traveling extensively worldwide to attend conferences, trade shows and technical seminars to identify emerging trends within the nutrition industry and locate new market opportunities for Fortitech and each of its global affiliates.

Schleif has nearly 10 years of experience in marketing and strategic media planning. Prior to joining Fortitech, Schleif served as director of advertising with an Albany, New York based PR marketing firm where he developed and negotiated multi-million dollar advertising campaigns throughout the United States. Schleif also worked with OMD Worldwide in New York City where he served in several capacities including associate director of strategy. Schleif holds a bachelor’s degree in business administration from Southern New Hampshire University. Schleif can be reached via email at schleif.rich[.]fortitech.com or by calling +518.372.5155.

Fortitech’s former director of marketing, Maria Battista, will now specialize in the strategic management and execution of Fortitech, Inc.’s global print and online advertising campaigns. Battista will also continue to serve as a key marketing player for Fortitech, Inc. and its global affiliates.

About Fortitech, Inc.
Founded in 1986, Fortitech, Inc. (fortitech.com) is the world leader in the development of custom nutrient premixes for the food, beverage and pharmaceutical industries, integrating functional ingredients from a comprehensive selection of vitamins, minerals, amino acids, nucleotides and nutraceuticals. Fortitech is ISO 9001:2000 and FPA certified and meets kosher and Halal standards. Headquartered in Schenectady, N.Y., the company has a global network of manufacturing and distribution facilities, throughout Europe, Asia Pacific, South America, Mexico and the United States (New York and California).

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Fortitech, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Fortitech, Inc. Continues Corporate Marketing Growth to Drive Premix Innovation and Market Expansion

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Mark Fanion 
518-372-5155 fanion.mark[.]fortitech.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Fortitech, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Fortitech, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Ipsen Announces Phase 3 CELESTIAL Trial of Cabozantinib Meets Primary Endpoint of Overall Survival
First Patient Treated with Microscopic Beads Pre-loaded with A Targeted Cancer Drug and Visible on CT Scans
BTG Plc Acquires Roxwood Medical
BTG and Mirada Medical Sign Three-Year Software Development Agreement
U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  NAKIVO, Inc.

Visit  JobsWare.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)